Pharmaceutical Science III - Anticancer, Antimetabolites & Alkylating agents (Dr. Hilliard)

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/53

encourage image

There's no tags or description

Looks like no tags are added yet.

54 Terms

1
New cards

what percentage of the US population will face a diagnosis of cancer during their lifetime

25%

2
New cards

what is chemotherapy

use of drugs to inhibit or kill proliferating cancer cells while leaving host cells unharmed or at least recoverable

3
New cards

what two classes of genes are involved in carcinogenesis

oncogenes
tumor suppressor genes (TP53)

4
New cards

when eradication of cancer is not am option what is considered

control of cancer

stop cancer from enlarging and spreading

extend survival and maintain quality of life

treat as chronic disease

5
New cards

adjuvant therapy

additional treatment given after primary treatment

chemo
radiation
hormone therapy
targeted therapy
biological therapy

6
New cards

neoadjuvant therapy

treatment given as first step to shrink tumor before main treatment; surgery
"induction therapy"

chemo
radiation
hormone therapy

7
New cards

supportive therapy

antiemetics (5HT3)

antibiotics

urate nephropathy (allopurinol)

analgesics

8
New cards

aggressive high dose chemo

dose limiting is toxic to normal cells (rescue therapy)

cyclic regimens for regeneration of normal cells

supportive therapy

9
New cards

what is given for hematotoxicity

bone marrow transplant, hematopoietic growth factors

10
New cards

what is given for MTX toxicity to reduce myelosuppression and mucositis

folate leucovorin

11
New cards

what is given as a detoxifying agent for urotoxicity and hemorrhagic cystitis with cyclophosphamide or ifosfamide

MENSA

12
New cards

what is used as chelating agent for iron and reduced anthracycline cardiotoxicity

dexrazoxane

13
New cards

what reduces hematotoxicity, nephrotoxicity and ototoxicity of cisplatin

amifostine

14
New cards

what is given to enhance efficacy of fluorouracil

leucovorin

15
New cards

cell cycle: G0

resting phase; non dividing

16
New cards

cell cycle: G1

cell grows

17
New cards

cell cycle: S

DNA replication

18
New cards

cell cycle: G2

cell prepares to divide

19
New cards

cell cycle: M

cell division; mitosis

20
New cards

what drug is used for G1

hydrocortisone

21
New cards

what drugs are used for S phase

antimetabolites
- purines
- thymidine
- folate antagonist

22
New cards

what drugs are used for G2

antibiotics
- bleomycin

23
New cards

what drugs are used for M phase

antimitotics

24
New cards

why are combo therapies used

- to enhance curative effects
- decrease toxicity
- reduce drug resistance

25
New cards

advantages of combo therapies

- maximal cell kill within range of tolerated toxicity
- effective for dividing and resting cancer cells
- slow or prevent development of resistance

26
New cards

t/f the aim of combo therapies is to urge more G0 phase cells to enter proliferating cycles to increase the amount of tumor cells killed by drugs

true

27
New cards

high GF tumors

S or M phases drugs used first then non specific to kill other cells then G0 to kill new cells

28
New cards

low GF tumors

solid tumors

non specific drugs used first then specific drugs then G0 phase to kill new cells

29
New cards

what cells are high GF cells

hair, GI, Skin, reproductive and bone marrow

30
New cards

combo of low GF and high GF drugs

does not increase toxicity but has synergism of action

31
New cards

drug resistance

- increased DNA repair
- formation of trapping agents
- changes in target enzymes
- decreased activation of prodrugs
- inactivation of drugs
- decreased drug accumulation

32
New cards

short term toxicity

appears with rapid proliferating cells
- myelosuppression
- GIT symptoms
- alopecia

33
New cards

what drugs does NOT have myelosuppression

bleomycin
vincristine
asparaginase
monoclonal antibodies
tyrosine kinase inhibitors

34
New cards

what drugs have GIT symptoms

cisplatin
cyclophosphamide/ifosfamide
doxorubicin/epirubicin

35
New cards

what drugs have hemorrhagic cystitis

ifosfamide (all doses)
cyclophosphamide (higher doses)

36
New cards

long term toxicity

carcinogenesis
teratogenesis
sterility

37
New cards

cancer drugs classes

antimetabolites
alkylating
natural
hormones
miscellaneous

38
New cards

antimetabolites

inhibit synthesis of DNA or RNA

effects S phase

antifolates
pyrimidine
purines

39
New cards

antimetabolites: antifolates

methotrexate
- inhibits dyhidrofolate reductase

TX:
- ALL
- Burkitts
- breast
- bladder
- head and neck
- RA and Crohns

S/E: myelosuppression, alopecia, liver toxic

40
New cards

antimetabolites: premetrexed

similar to MTX

Tx: non small cell lung cancer

give folic acid as resuce

41
New cards

antimetabolites: purine

mercaptupurine

first used in cancer tx
- ALL and CML

inhibits purine synthesis by inhibiting enzyme HGPRTases

S/E: N/V/D, myelosuppression, liver toxic, anorexia

42
New cards

antimetabolites: pyrimidine

5-FU
-inhibits thymidine synthesis

TX:
breast
colorectal
ovarian
pancreatic
gastric

S/E: diarrhea, myelosuppression, alopecia

43
New cards

antimetabolites: capecitabine

not cytotoxic until converted to 5-FU

TX:
colorectal
breast

S/E: neutropenia, thrombocytopenia, anemia, hand-foot syndrome

44
New cards

alkylating agents are the ___ and ___ used

oldest
most

45
New cards

t/f clinical use evolved from soldiers exposed during WWI to sulfur mustard gas and experienced bone marrow suppression and lymph node shrinkage

true

46
New cards

t/f alkylating agents are cell cycle non specific

true

47
New cards

where is the most common binding site for alkylating agents

@ N-7 on DNA guanine

48
New cards

alkylating: cyclophosphamide

moa: DNA crosslinking (intra or inter) and blocking DNA replication

TX:
breast
ovarian
CLL
non-hodgkins
neuroblastoma

S/E: myelosuppression, alopecia, hemorrhagic cystitis, N/V

49
New cards

what are 2 active agents for cyclophosphamide

4- hydroxycyclophosphamide
aldophosphamide

50
New cards

what are the 2 INactive agents with cyclophosphamide

4-ketocyclophosphamide
carboxyphosphamide

51
New cards

what are the 2 cytotoxic agents with cyclophosphamide

acrolein
phosphoramide mustard

52
New cards

while ifosfamide must be converted to cyclophosphamide, encephalopathy may occur within

48-72 hrs

53
New cards

alkylating: mechlorethamine

TX: Hodgkins and non-Hodgkins

S/E: GI, alopecia, sterility, myelosuppression

54
New cards

alkylating: procarbazine

TX: Hodgkins and non-Hodgkins, brain tumors

S/E: myelosuppression, GI, CNS, peripheral, skin